Infectious complications in hiv patients and large b cell lymphoma at the instituto nacional de cancerologÿa, mexico

BACKGROUND: The Diffuse Large B Cell Lymphoma (DLBCL) is the most common Non Hodgkin Lymphoma. The frequency and type of infections in patients with DLBCL and HIV, and the impact on the survival are still unknown. METHODS: We performed an observational, retrospective, longitudinal study in patients...

Full description

Bibliographic Details
Main Authors: V. Bravo Villa, A. Martin, A.F. Ramírez
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Hematology Reports
Online Access:https://www.pagepress.org/journals/index.php/hr/article/view/8925
_version_ 1797935622291193856
author V. Bravo Villa
A. Martin
A.F. Ramírez
author_facet V. Bravo Villa
A. Martin
A.F. Ramírez
author_sort V. Bravo Villa
collection DOAJ
description BACKGROUND: The Diffuse Large B Cell Lymphoma (DLBCL) is the most common Non Hodgkin Lymphoma. The frequency and type of infections in patients with DLBCL and HIV, and the impact on the survival are still unknown. METHODS: We performed an observational, retrospective, longitudinal study in patients with DLBCL with and without HIV, that receive chemotherapy treatment from 2010-2019 at the Instituto Nacional de Cancerología, México. RESULTS: We analyzed 170 patients; 56 patients with HIV and 114 without HIV. We observed a predominance of male gender and advanced stage in both groups. During the first year of chemotherapy, 46% of patients without HIV and 70% with HIV, had an infectious complication. (p=0.0001). Gram-negative Enterobacteria predominated, with a pattern of sensibility pan sensible. In the bivariate analyses, hypoalbuminemia, high ECOG score, EPOCH chemotherapy and HIV positivity status were associated with the presence of infections. One episode of infection was associated with a decrease in Event free survival (EFS) (RR 2.14, p=0.007) and Overall Survival (OS) (RR 2.5, p=0.001), independently of the HIV status. In the multivariate analysis for OS, infections at diagnosis and Central Nervous System (CNS) infiltration were independent prognostic factors for survival. DISCUSSION: Patients with HIV infection and lymphoma have higher number of infections than patients without HIV, however HIV positivity status does not impact the survival of these patients. The functional and nutritional deterioration were associated with the development of infections in the entire cohort. Infections had an impact on EFS and OS, regardless of HIV status.
first_indexed 2024-04-10T18:18:01Z
format Article
id doaj.art-75d9cfeeed1d43a495d8380f4258c67e
institution Directory Open Access Journal
issn 2038-8322
2038-8330
language English
last_indexed 2024-04-10T18:18:01Z
publishDate 2020-09-01
publisher MDPI AG
record_format Article
series Hematology Reports
spelling doaj.art-75d9cfeeed1d43a495d8380f4258c67e2023-02-02T08:09:03ZengMDPI AGHematology Reports2038-83222038-83302020-09-0112s1Infectious complications in hiv patients and large b cell lymphoma at the instituto nacional de cancerologÿa, mexicoV. Bravo Villa0A. Martin1A.F. Ramírez2Instituto Nacional de CancerologíaInstituto Nacional de CancerologíaInstituto Nacional de CancerologíaBACKGROUND: The Diffuse Large B Cell Lymphoma (DLBCL) is the most common Non Hodgkin Lymphoma. The frequency and type of infections in patients with DLBCL and HIV, and the impact on the survival are still unknown. METHODS: We performed an observational, retrospective, longitudinal study in patients with DLBCL with and without HIV, that receive chemotherapy treatment from 2010-2019 at the Instituto Nacional de Cancerología, México. RESULTS: We analyzed 170 patients; 56 patients with HIV and 114 without HIV. We observed a predominance of male gender and advanced stage in both groups. During the first year of chemotherapy, 46% of patients without HIV and 70% with HIV, had an infectious complication. (p=0.0001). Gram-negative Enterobacteria predominated, with a pattern of sensibility pan sensible. In the bivariate analyses, hypoalbuminemia, high ECOG score, EPOCH chemotherapy and HIV positivity status were associated with the presence of infections. One episode of infection was associated with a decrease in Event free survival (EFS) (RR 2.14, p=0.007) and Overall Survival (OS) (RR 2.5, p=0.001), independently of the HIV status. In the multivariate analysis for OS, infections at diagnosis and Central Nervous System (CNS) infiltration were independent prognostic factors for survival. DISCUSSION: Patients with HIV infection and lymphoma have higher number of infections than patients without HIV, however HIV positivity status does not impact the survival of these patients. The functional and nutritional deterioration were associated with the development of infections in the entire cohort. Infections had an impact on EFS and OS, regardless of HIV status.https://www.pagepress.org/journals/index.php/hr/article/view/8925
spellingShingle V. Bravo Villa
A. Martin
A.F. Ramírez
Infectious complications in hiv patients and large b cell lymphoma at the instituto nacional de cancerologÿa, mexico
Hematology Reports
title Infectious complications in hiv patients and large b cell lymphoma at the instituto nacional de cancerologÿa, mexico
title_full Infectious complications in hiv patients and large b cell lymphoma at the instituto nacional de cancerologÿa, mexico
title_fullStr Infectious complications in hiv patients and large b cell lymphoma at the instituto nacional de cancerologÿa, mexico
title_full_unstemmed Infectious complications in hiv patients and large b cell lymphoma at the instituto nacional de cancerologÿa, mexico
title_short Infectious complications in hiv patients and large b cell lymphoma at the instituto nacional de cancerologÿa, mexico
title_sort infectious complications in hiv patients and large b cell lymphoma at the instituto nacional de cancerologya mexico
url https://www.pagepress.org/journals/index.php/hr/article/view/8925
work_keys_str_mv AT vbravovilla infectiouscomplicationsinhivpatientsandlargebcelllymphomaattheinstitutonacionaldecancerologyamexico
AT amartin infectiouscomplicationsinhivpatientsandlargebcelllymphomaattheinstitutonacionaldecancerologyamexico
AT aframirez infectiouscomplicationsinhivpatientsandlargebcelllymphomaattheinstitutonacionaldecancerologyamexico